Spero Therapeutics Inc (SPRO)
0.9597
-0.04
(-3.84%)
USD |
NASDAQ |
Dec 20, 16:00
0.955
0.00 (0.00%)
After-Hours: 04:09
Spero Therapeutics Profit Margin (Quarterly): -219.3% for Sept. 30, 2024
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| CytomX Therapeutics Inc | 17.16% |
| Castle Biosciences Inc | 2.65% |
| Arbutus Biopharma Corp | -1.47K% |
| PTC Therapeutics Inc | -54.20% |
| Equillium Inc | -0.06% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | 4.36% |
| Return on Assets | 2.37% |
| Return on Invested Capital | 4.36% |
| Operating Margin (Quarterly) | -237.8% |
| Return on Net Operating Assets | 7.41% |